Advent Pharma Ltd. (DSE:ADVENT)
Bangladesh · Delayed Price · Currency is BDT 14.40
+0.20 (1.41%)
At close: Nov 12, 2026
Advent Pharma Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 401.85 | 500.49 | 571.67 | 558.05 | 530.47 | |
Revenue Growth | -19.71% | -12.45% | 2.44% | 5.20% | 5.34% |
Cost of Revenue | 280.18 | 324.86 | 343.77 | 335.14 | 310.31 |
Gross Profit | 121.68 | 175.63 | 227.9 | 222.91 | 220.16 |
Selling, General & Admin | 59.12 | 80.04 | 86.26 | 87.55 | 86.78 |
Operating Expenses | 59.12 | 80.04 | 86.26 | 87.55 | 86.78 |
Operating Income | 62.56 | 95.58 | 141.65 | 135.36 | 133.38 |
Interest Expense | -11.74 | -9.16 | -8.09 | -6.63 | -4.11 |
Interest & Investment Income | - | 0.02 | 0.02 | 0.01 | 1.1 |
Other Non Operating Income (Expenses) | 0.06 | -0.16 | -0.18 | -0.11 | -0.08 |
EBT Excluding Unusual Items | 50.88 | 86.29 | 133.39 | 128.63 | 130.3 |
Gain (Loss) on Sale of Assets | 0.27 | - | -29.61 | - | - |
Pretax Income | 51.14 | 86.29 | 103.78 | 128.63 | 130.3 |
Income Tax Expense | 12.24 | 19.41 | 19.79 | 29.99 | 32.76 |
Net Income | 38.9 | 66.87 | 83.99 | 98.64 | 97.53 |
Net Income to Common | 38.9 | 66.87 | 83.99 | 98.64 | 97.53 |
Net Income Growth | -41.83% | -20.38% | -14.85% | 1.14% | -14.14% |
Shares Outstanding (Basic) | 93 | 93 | 93 | 93 | 93 |
Shares Outstanding (Diluted) | 93 | 93 | 93 | 93 | 93 |
Shares Change | -0.55% | - | - | - | - |
EPS (Basic) | 0.42 | 0.72 | 0.90 | 1.06 | 1.05 |
EPS (Diluted) | 0.42 | 0.72 | 0.90 | 1.06 | 1.05 |
EPS Growth | -41.51% | -20.38% | -14.85% | 1.14% | -14.14% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 2.16 | 20.56 | 13.08 | 2.56 | -11.56 |
Free Cash Flow Per Share | 0.02 | 0.22 | 0.14 | 0.03 | -0.12 |
Dividend Per Share | - | 0.050 | 0.100 | 0.200 | 0.200 |
Dividend Growth | - | -50.00% | -50.00% | 0% | 1.99% |
Gross Margin | 30.28% | 35.09% | 39.87% | 39.95% | 41.50% |
Operating Margin | 15.57% | 19.10% | 24.78% | 24.26% | 25.14% |
Profit Margin | 9.68% | 13.36% | 14.69% | 17.68% | 18.39% |
Free Cash Flow Margin | 0.54% | 4.11% | 2.29% | 0.46% | -2.18% |
EBITDA | 122.32 | 158.05 | 207.57 | 193.96 | 175.07 |
EBITDA Margin | 30.44% | 31.58% | 36.31% | 34.76% | 33.00% |
D&A For EBITDA | 59.76 | 62.47 | 65.93 | 58.6 | 41.69 |
EBIT | 62.56 | 95.58 | 141.65 | 135.36 | 133.38 |
EBIT Margin | 15.57% | 19.10% | 24.78% | 24.26% | 25.14% |
Effective Tax Rate | 23.94% | 22.50% | 19.07% | 23.31% | 25.15% |
Advertising Expenses | - | 0.12 | 0.15 | 0.19 | 0.18 |